Lifecare AS (DE:LFC) has released an update.
Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
Lifecare ASA has reported a significant milestone in their development of a next-generation Continuous Glucose Monitor (CGM), with their Sencell sensor demonstrating an operational lifespan of four weeks in a live tissue trial on a dog named Elli. This achievement surpasses the longevity of some current CGM sensors and confirms the sensor’s long-term functionality and technology. The successful trial data provides a strong foundation for Lifecare’s ongoing efforts to improve the lives of people and animals with diabetes.
For further insights into DE:LFC stock, check out TipRanks’ Stock Analysis page.
